Risk factors, structural brain abnormalities and cognitive function in individuals with type 2 diabetes
Principal Investigator: Dr Thomas van Sloten
Approved Research ID: 60842
Approval date: April 3rd 2020
Individuals with diabetes have a higher risk of developing dementia compared to individuals without diabetes. The extent to which this excess risk may be reduced by current treatment is unclear. Current treatment consists of targeting multiple factors, including high blood sugar levels, elevated blood pressure, being overweight, smoking and elevated protein levels in urine. In this project, we will evaluate whether the higher risk of dementia in diabetes could be reduced by this multifactorial treatment. This will inform patients and medical doctors about the potential beneficial effects of current treatments. The estimated project duration is 12 months.